Cite
MLA Citation
Flonza Isa et al.. “Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.” International journal of infectious diseases, vol. 122, 2022, pp. 585–592. http://access.bl.uk/ark:/81055/vdc_100164417856.0x00002c